Diabetes Technology Society
Public records show a registered, tax-exempt organization in good standing.
What it says it does
TO FACILITATE RESEARCH INTO THE TREATMENT, MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES.
- Income
- $1.0 million
- Spending
- $1.6 million
- Spent on programs
- 87%
- Reserves
- 10.4 months of spending
- Largest source of income
- fees for its services, 77%
- Employees
- 6
- Volunteers
- 0
- Highest pay
- $306,747, president
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Fair: 63 out of 100. Higher than 23% of charities in its peer group (diseases, $1m to $10m).
Reserves
28 of 35Spendable reserves would cover 10.4 months of spending.
Debt
20 of 20It owes 1% of what it owns.
Living within its means
0 of 15Spending exceeded income by 57% of income.
Income trend
0 of 15Income fell 47% on the year before.
Spending floor
15 of 1587% of spending went to programs and raising each dollar of donations cost 0 cents.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Weak: 48 out of 100. Higher than 5% of charities in its peer group (diseases, $1m to $10m).
Independent board
18 of 253 of 4 voting board members are independent.
Conflict of interest policy
0 of 15Reports no written conflict of interest policy.
Whistleblower policy
0 of 8Reports no written whistleblower policy.
Record keeping policy
0 of 7Reports no written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
0 of 15Its accounts were not audited or reviewed by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (1)
- $1.4 million spent. TO FURTHER EDUCATION PROFESSIONALS AND THE PUBLIC ON THE TREATMENT, MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES. THIS WAS ACHIEVED BY HOLDING EDUCATIONAL CONFERENCES, MAINTAINING AN INFORMATIONAL WEBSITE, HOLDING AN ONGOING PODCAST WITH LEADERS IN THE DIABETES TECHNOLOGY FIELD, MAINTAINING A SPANISH/ENGLISH DUAL-LANGUAGE INFORMATIONAL WEBSITE AND PUBLISHING 204 TECHNICAL ARTICLES AND 13 RESEARCH ARTICLES ABOUT DIABETES AND DIABETES TECHNOLOGY. CONFERENCES HELD IN 2025, THE NUMBER OF ATTENDEES AND OTHER PROJECTS ARE AS FOLLOWS:1.TOOLS TO DISTINGUISH T1D & T2D IN ADULTS (TOOLS PROJECT)MEETING #1: 2/4/2025, 14 ATTENDEESMEETING #2: 2/5/2025, 14 ATTENDEESMEETING #3: 5/29/2025: 29 ATTENDEESMEETING #4: 8/13/2025, 14 ATTENDEES2. INTEGRATION OF CONNECTED DIABETES DEVICE DATA INTO THE ELECTRONIC HEALTH RECORD #2 (ICODE-2)SEPTEMBER 18, 2025NO. OF ATTENDEES: 403. THE ROLE OF THE GLYCEMIA RISK INDEX DIABETES TECHNOLOGY MEETING (GRI MEETING)OCTOBER 27, 2025NO. OF ATTENDEES: 484. DIABETES TECHNOLOGY MEETING (IN-PERSON) (DTM 2025)OCTOBER 28-30, 2025NO. OF ATTENDEES: 5005. THE USE OF CGM TO DIAGNOSE STAGE 2 T1D CONSENSUS PANEL (IN-PERSON PRESENTATION AT THE 2025 DTM)OCTOBER 30, 2025 NO. OF ATTENDEES: 500ONGOING PROJECTS:1. DIABETES RESEARCH HUB (DRH) - ONGOING PROJECTTHE DRH IS A COMPREHENSIVE DATA ECOSYSTEM DESIGNED TO ACCELERATE BREAKTHROUGHS IN DIABETES RESEARCH. WE EMPOWER RESEARCHERS BY UNLOCKING THE POTENTIAL OF DATA TRAPPED IN PROPRIETARY MEDICAL DEVICES AND HEALTH SYSTEMS. BY CREATING A SECURE AND USER-FRIENDLY PLATFORM FOR DATA COLLECTION, ANALYSIS, AND COLLABORATION, THE DRH FUELS NEXT-GENERATION RESEARCH USING AI AND ML TO DEVELOP PERSONALIZED AND EFFECTIVE SOLUTIONS FOR DIABETES.2. THE DCB OPEN INNOVATION CHALLENGEIN COLLABORATION WITH DIABETES CENTER BERNEONGOING - LAUNCHED ON 4/1/2024 & FEATURED AT THE DTM 2025 ON 10/30/20253. DIABETES TECHNOLOGY REPORT(DTS PODCAST)DTS LAUNCHED AN ONGOING PODCAST WITH LEADERS IN THE DIABETES TECHNOLOGY FIELD.4. SALUDDIABETES.ORGDTS LAUNCHED A SPANISH/ENGLISH DUAL-LANGUAGE WEBSITE THAT SUMMARIZES RECENT PUBLICATIONS IN DIABETES AND HEALTH FOR THE LAYPERSON.5. OPTIMIZING LIFESTYLE INTERVENTIONS FOR REVERSING INSULIN RESISTANCE - ONGOING PROJECTTO ANALYZE MEDICAL LITERATURE FOR INTERVENTIONS THAT IMPROVE INSULIN SENSITIVITY (EITHER BY AN EFFECT ON THE LIVER, MUSCLES, OR PRODUCTION OF INSULIN OR NATURAL GLP-1RA HORMONE) THAT COULD BECOME PART OF A BEHAVIORAL TOOL TO BE USED FOR PEOPLE WITH PREDIABETES OR WHO ARE AT RISK OF DIABETES TO DECREASE THEIR RISK OF DEVELOPING TYPE 2 DIABETES.6. JDST (JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY)PUBLISHED 204 TECHNICAL ARTICLES ABOUT DIABETES AND DIABETES TECHNOLOGY AFTER RECEIVING 628 ARTICLES TO REVIEW.7. PUBLICATION OF 13 RESEARCH ARTICLES BY DTS STAFF LISTED BELOW:-EVALUATING THE CLINICAL UTILITY OF THE GLYCEMIA RISK INDEX.J DIABETES SCI TECHNOL. 2025 OCT 14:19322968251382604. DOI: 10.1177/19322968251382604. ONLINE AHEAD OF PRINT. PMID: 41216978 FREE PMC ARTICLE.-MACHINE LEARNING TO DIAGNOSE COMPLICATIONS OF DIABETES. J DIABETES SCI TECHNOL. 2025 NOV;19(6):1650-1670. DOI: 10.1177/19322968251365245. EPUB 2025 SEP 11. PMID: 40932163 FREE PMC ARTICLE. REVIEW.-CONTINUOUS GLUCOSE MONITORING DATA ANALYSIS 2.0: FUNCTIONAL DATA PATTERN RECOGNITION AND ARTIFICIAL INTELLIGENCE APPLICATIONS. J DIABETES SCI TECHNOL. 2025 NOV;19(6):1515-1527. DOI: 10.1177/19322968251353228. EPUB 2025 AUG 14. PMID: 40814224 FREE PMC ARTICLE.-GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND PERI-PROCEDURAL ASPIRATION RISK. J ENDOCR SOC. 2025 JUL 10;9(9):BVAF088. DOI: 10.1210/JENDSO/BVAF088. ECOLLECTION 2025 SEP. PMID: 40893948 FREE PMC ARTICLE. REVIEW.-THE NEED TO TRANSITION FROM PAPER TO ELECTRONIC INSTRUCTIONS FOR USE FOR DIABETES DEVICES. NPJ DIGIT MED. 2025 JUN 13;8(1):356. DOI: 10.1038/S41746-025-01720-0. PMID: 40514391 FREE PMC ARTICLE.-DIABETES DEVICES: A GROWING ENVIRONMENTAL BURDEN. DIABETES RES CLIN PRACT. 2025 AUG;226:112307. DOI: 10.1016/J.DIABRES.2025.112307. EPUB 2025 JUN 3. PMID: 40473032 NO ABSTRACT AVAILABLE.-USE OF CONTINUOUS GLUCOSE MONITORING TO DIAGNOSE STAGE 2 TYPE 1 DIABETES. J DIABETES SCI TECHNOL. 2025 JUL;19(4):1109-1127. DOI: 10.1177/19322968251333441. EPUB 2025 MAY 30. PMID: 40444471 FREE PMC ARTICLE. REVIEW.-ENVISIONING TOOLS TO HELP CLASSIFY TYPE 1 DIABETES AND TYPE 2 DIABETES IN NEW-ONSET ADULT DIABETES. J DIABETES SCI TECHNOL. 2025 JUL;19(4):1137-1143. DOI: 10.1177/19322968251329055. EPUB 2025 MAR 28. PMID: 40152433 FREE PMC ARTICLE.-QUANTIFYING ENVIRONMENTAL WASTE FROM DIABETES DEVICES IN THE U.S. DIABETES CARE. 2025 JUL 1;48(7):1198-1203. DOI: 10.2337/DC24-2522. PMID: 40072890.-HOW TO PROVIDE ADDITIONAL OVERSIGHT TO ENSURE THAT REMOTE PATIENT MONITORING FOR PEOPLE WITH DIABETES IS BEING USED AND BILLED APPROPRIATELY. DIABETES SCI TECHNOL. 2025 MAY;19(3):843-849. DOI: 10.1177/19322968241309357. EPUB 2025 JAN 16. PMID: 39819165 FREE PMC ARTICLE.-HOW THE DIABETES RESEARCH HUB WILL MODERNIZE AND ENHANCE DIABETES DATA UTILIZATION. J DIABETES SCI TECHNOL. 2026 JAN;20(1):3-6. DOI: 10.1177/19322968241306129. EPUB 2024 DEC 21. PMID: 39707843 FREE PMC ARTICLE.-COMPARISON OF THE GLYCEMIA RISK INDEX AND TIME IN RANGE IN A CASE SERIES OF USING AUTOMATED INSULIN DELIVERY TO IMPROVE GLYCEMIC CONTROL IN PEOPLE WITH TYPE 1 DIABETES AND END STAGE KIDNEY DISEASE ON HEMODIALYSIS. DIABETES RES CLIN PRACT. 2025 JAN;219:111940. DOI: 10.1016/J.DIABRES.2024.111940. EPUB 2024 NOV 29. PMID: 39615793 NO ABSTRACT AVAILABLE.-CONSENSUS REPORT ON THE USE OF CONTINUOUS GLUCOSE MONITORING IN CHRONIC KIDNEY DISEASE AND DIABETES. J DIABETES SCI TECHNOL. 2025 JAN;19(1):217-245. DOI: 10.1177/19322968241292041. EPUB 2024 NOV 29. PMID: 39611379 FREE PMC ARTICLE.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since April 2002.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.